embozene color-advanced microspheres

Embozene Color-Advanced Microspheres are embolic agents designed for precise arterial embolization. They are used to occlude blood vessels in order to treat conditions such as tumors and uterine fibroids.

These microspheres are commonly used in procedures like uterine artery embolization and transcatheter arterial chemoembolization. They are employed in scenarios requiring targeted vessel occlusion to manage bleeding or reduce tumor blood supply.

The literature includes 15 studies, comprising RCTs, prospective, and retrospective analyses, published between 2018 and 2025. These studies explore various clinical applications and outcomes of using Embozene microspheres.

Published studies report that Embozene microspheres are effective in reducing symptoms of uterine fibroids and adenomyosis when used in uterine artery embolization. They have also shown efficacy in transcatheter arterial chemoembolization for hepatocellular carcinoma, with outcomes indicating significant tumor necrosis.

Reported complications include minor post-procedural pain and transient inflammatory responses. Overall, the safety profile is consistent with other embolic agents, with no significant long-term adverse events reported in the studies.

Current evidence is limited by the variability in study design and small sample sizes in some studies. Further research is needed to establish long-term outcomes and compare efficacy across different embolic agents.